U.S. Markets open in 6 hrs 32 mins

China Pharma Holdings, Inc. (CPHI)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.199-0.001 (-0.450%)
At close: 3:50PM EDT
People also watch
SKBIALNCMFOCREGCHME
Full screen
Previous Close0.200
Open0.200
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.190 - 0.200
52 Week Range0.150 - 0.350
Volume52,634
Avg. Volume190,912
Market Cap8.67M
Beta2.13
PE Ratio (TTM)-1.03
EPS (TTM)-0.19
Earnings DateNov 13, 2017 - Nov 17, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Trade prices are not sourced from all markets
  • ACCESSWIRE8 days ago

    Corporate News Blog - GlaxoSmithKline Declares Publication of Phase-III Results Of Mepolizumab in Patients with Eosinophilic COPD at Risk of Exacerbations

    Research Desk Line-up: China Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 14, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for ...

  • PR Newswire9 days ago

    China Pharma Holdings, Inc. Announces Notification of NYSE American Listing Deficiency

    HAIKOU, China, Sept. 12, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) (the "Company") today announced receipt of notification (the "Deficiency Letter") from the NYSE AMERICAN LLC ("NYSE American") that the Company is not in compliance with certain NYSE American continued listing standards or the Listing Standards. The Deficiency Letter indicated that the Company's securities have been selling for a low price per share for a substantial period of time and, most recently, the average price of the Company's common stock had been below $0.20 on a 30-day average as of September 5, 2017. Pursuant to Section 1003(f)(v) of the NYSE American Company Guide, the NYSE American staff determined that the Company's continued listing is predicated on it effecting a reverse stock split of its common stock or otherwise demonstrating sustained price improvement within a reasonable period of time, which the staff determined to be until March 6, 2018.

  • China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
    Capital Cubelast month

    China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017

    Categories: Yahoo FinanceGet free summary analysis China Pharma Holdings, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of China Pharma Holdings, Inc. – Mylan N.V., Teva Pharmaceutical Industries Limited Sponsored ADR, Dr. Reddy’s Laboratories Ltd. Sponsored ADR, China Biologic Products Holdings, Inc., Novartis AG Sponsored ... Read more (Read more...)